Pharmaceuticals, Biotechnology and Life Sciences
– $20M Tranche Available on Approval of Tivozanib – BOSTON–(BUSINESS WIRE)–AVEO Oncology (Nasdaq: AVEO) today announced that it has received…
Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio NEW YORK–(BUSINESS WIRE)–Turnstone…
STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #COVID19—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential…
U.S. Food and Drug Administration assigned a target action date of May 20, 2021 Application based on Phase 3 CheckMate…
U.S. Food and Drug Administration assigned a target action date of May 25, 2021 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb…
U.S. Food and Drug Administration assigned a target action date of May 25, 2021 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb…
VERQUVO Approved for Reduction of Risk of Cardiovascular Death and Heart Failure (HF) Hospitalization Following a Hospitalization for HF or…
VERQUVO Approved for Reduction of Risk of Cardiovascular Death and Heart Failure (HF) Hospitalization Following a Hospitalization for HF or…
NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–#biopharmaceutical–Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or “Aptorum”), a…